MedPlus Subsidiary Faces Three-Day Drug License Suspensions at Three Karnataka Stores

Claim 70% Off TipRanks This Holiday SeasonUnlock hedge-fund level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potentialMedPlus Health Services Ltd. ( (IN:MEDPLUS) ) has shared an announcement. MedPlus Health Services Ltd. has disclosed that its subsidiary Optival Health Solutions Private Limited has received three suspension orders for drug licenses covering three stores in Karnataka, located at Jayanagar 9th Block, T R Nagar, and Shiggon Haveri. The suspensions, issued by Assistant Directors of the Drugs Control Administration in Bangalore Circle-3 and Haveri Circle under Rule 65 of the Drugs and Cosmetics Act, 1940 and corresponding Rules, each apply for a three-day period and are linked to alleged violations of those provisions. The company estimates a combined potential revenue loss of roughly Rs 3.24 lakh from the temporary shutdowns, indicating a limited financial impact relative to overall operations, but highlighting ongoing regulatory scrutiny over compliance in its retail pharmacy network. More about MedPlus Health Services Ltd. MedPlus Health Services Ltd. operates in the Indian retail pharmacy and healthcare services industry, primarily through its chain of MedPlus pharmacies and subsidiary Optival Health Solutions Private Limited. The company focuses on providing prescription drugs, over-the-counter medicines and related healthcare products across multiple states, positioning itself as a major organized pharmacy player in urban and semi-urban markets. Average Trading Volume: 21,726 Technical Sentiment Signal: Buy Current Market Cap: 98.84B INR See more insights into MEDPLUS stock on TipRanks’ Stock Analysis page.